Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functional Limitations

BACKGROUND: A methotrexate autoinjector (MTXAI) was developed for self-administration of subcutaneous (SC) methotrexate by patients with rheumatoid arthritis (RA). The MTXAI circumvents the need for vials, needles, and syringes and may therefore improve dosing accuracy, handling risks, and patient a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Freundlich, Bruce, Kivitz, Alan, Jaffe, Jonathan S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Lippincott Williams & Wilkins 2014
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165470/
https://ncbi.nlm.nih.gov/pubmed/25036562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000000117
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk